Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Ethyldeshydroxy-sparsomycin as modulator of antitumour response

Hofs, H.P.

Publication date

January 1995

Publisher

[S.l. : s.n.]

Abstract

Contains fulltext : mmubn000001_194226832.pdf (publisher's version ) (Open Access)Promotores : D. Wagener en H. Ottenheijm219 p

Extracted data

Related items

Ondansetron, a serotonin 5-HT3 receptor antagonist: clinical studies in cytotoxic chemotherapy

Seynaeve, C.

January 1991

Contains fulltext : mmubn000001_125681208.pdf (publisher's version ) (Open Access)...

400 Copyright © 2013 The Korean Society of Cardiology Korean Circulation Journal

August 2016

Doxorubicin is a glycosidic anthracycline anticancer drug, and it was first isolated from Streptomyc...

Sialic acid mimetics for cancer immunotherapy

Büll, C.

January 2017

Contains fulltext : 169260.pdf (publisher's version ) (Open Access)Radboud Univers...

Sparsomycin and its analogues: a preclinical study on novel anticancer drugs

Zylicz, Z.

January 1988

Contains fulltext : mmubn000001_065390628.pdf (publisher's version ) (Open Access)...

Chemotherapy against streptococcus mutans

Schaeken, M.J.M.

January 1984

Contains fulltext : mmubn000001_027884783.pdf (publisher's version ) (Open Access)...

Activity and reduced toxicity of liposome entrapped doxorubicin

Hoesel, Q.G.C.M. van

January 1985

Contains fulltext : mmubn000001_028894170.pdf (publisher's version ) (Open Access)...

The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity

Hofs, H.P.
Wagener, D.J.T.
Valk-Bakker, V. de
Rennes, H. van
Doesburg, W.H.
Ottenheijm, H.C.J.
Grip, W.J. de

January 1997

Contains fulltext : 25027___.PDF (publisher's version ) (Open Access

New approaches in selective chemotherapy with tumor-activated prodrugs

Groot, F.M.H. de

January 2002

Contains fulltext : mmubn000001_387492534.pdf (publisher's version ) (Closed acces...

Synthesis of prodrugs of anthracyclines and evaluation of their use in selective chemotherapy

Leenders, R.G.G.

January 1998

Contains fulltext : 18595.pdf (publisher's version ) (Open Access)This thesis is d...

Synthesis of some daunomycin-type anti-tumor anthracyclines and evaluation of their biological activity

Bie, Joannes Franciscus Martinus de

January 2007

Contains fulltext : mmubn000001_215799097.pdf (publisher's version ) (Open Access)...

Targeting adrenomedullin in sepsis

Geven, C.B.C.A.G.

January 2019

Contains fulltext : 201197.pdf (publisher's version ) (Open Access)Radboud Univers...

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer

Punt, C.J.A.
Voest, E.E.
Tueni, E.
Oosterom, A. van
Backx, A.P.C.M.
Mulder, P.H.M. de
Hecquet, B.
Lucas, C.
Gerard, B.
Bleiberg, H.

January 1997

Contains fulltext : 24647___.PDF (publisher's version ) (Open Access

Improving cancer immunotherapy by targeting the STATe of MDSCs

Haas, N. de
Koning, C.
Spilgies, L.
Vries, I.J.M. de
Hato, S.V.

January 2016

Contains fulltext : 172778.pdf (Publisher’s version ) (Open Access)Cancer immunoth...

Immunotherapy of B-cell malignancies with monoclonal anti-idiotypic antibodies

Allebes, W.A.

January 1989

Contains fulltext : mmubn000001_079379966.pdf (publisher's version ) (Open Access)...

Running title: camptothecin-bombesin conjugates Correspondence and Reprints to:

Terry W. Moody
Li-chun Sun
Samuel A. Mantey
Tapas Pradhan
L. Vienna Mackey
Nieves Gonzales
Joseph A. Fuselier
David H. Coy
Robert T. Jensen
Dr. Terry
W. Moody

October 2016

1 In vitro and in vivo anti-tumor effects of cytotoxic camptothecin-bombesin conjugates are mediated...

Ondansetron, a serotonin 5-HT3 receptor antagonist: clinical studies in cytotoxic chemotherapy

Seynaeve, C.

January 1991

Contains fulltext : mmubn000001_125681208.pdf (publisher's version ) (Open Access)...

400 Copyright © 2013 The Korean Society of Cardiology Korean Circulation Journal

August 2016

Doxorubicin is a glycosidic anthracycline anticancer drug, and it was first isolated from Streptomyc...

Sialic acid mimetics for cancer immunotherapy

Büll, C.

January 2017

Contains fulltext : 169260.pdf (publisher's version ) (Open Access)Radboud Univers...

Sparsomycin and its analogues: a preclinical study on novel anticancer drugs

Zylicz, Z.

January 1988

Contains fulltext : mmubn000001_065390628.pdf (publisher's version ) (Open Access)...

Chemotherapy against streptococcus mutans

Schaeken, M.J.M.

January 1984

Contains fulltext : mmubn000001_027884783.pdf (publisher's version ) (Open Access)...

Activity and reduced toxicity of liposome entrapped doxorubicin

Hoesel, Q.G.C.M. van

January 1985

Contains fulltext : mmubn000001_028894170.pdf (publisher's version ) (Open Access)...

The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity

Hofs, H.P.
Wagener, D.J.T.
Valk-Bakker, V. de
Rennes, H. van
Doesburg, W.H.
Ottenheijm, H.C.J.
Grip, W.J. de

January 1997

Contains fulltext : 25027___.PDF (publisher's version ) (Open Access

New approaches in selective chemotherapy with tumor-activated prodrugs

Groot, F.M.H. de

January 2002

Contains fulltext : mmubn000001_387492534.pdf (publisher's version ) (Closed acces...

Synthesis of prodrugs of anthracyclines and evaluation of their use in selective chemotherapy

Leenders, R.G.G.

January 1998

Contains fulltext : 18595.pdf (publisher's version ) (Open Access)This thesis is d...

Synthesis of some daunomycin-type anti-tumor anthracyclines and evaluation of their biological activity

Bie, Joannes Franciscus Martinus de

January 2007

Contains fulltext : mmubn000001_215799097.pdf (publisher's version ) (Open Access)...

Targeting adrenomedullin in sepsis

Geven, C.B.C.A.G.

January 2019

Contains fulltext : 201197.pdf (publisher's version ) (Open Access)Radboud Univers...

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer

Punt, C.J.A.
Voest, E.E.
Tueni, E.
Oosterom, A. van
Backx, A.P.C.M.
Mulder, P.H.M. de
Hecquet, B.
Lucas, C.
Gerard, B.
Bleiberg, H.

January 1997

Contains fulltext : 24647___.PDF (publisher's version ) (Open Access

Improving cancer immunotherapy by targeting the STATe of MDSCs

Haas, N. de
Koning, C.
Spilgies, L.
Vries, I.J.M. de
Hato, S.V.

January 2016

Contains fulltext : 172778.pdf (Publisher’s version ) (Open Access)Cancer immunoth...

Immunotherapy of B-cell malignancies with monoclonal anti-idiotypic antibodies

Allebes, W.A.

January 1989

Contains fulltext : mmubn000001_079379966.pdf (publisher's version ) (Open Access)...

Running title: camptothecin-bombesin conjugates Correspondence and Reprints to:

Terry W. Moody
Li-chun Sun
Samuel A. Mantey
Tapas Pradhan
L. Vienna Mackey
Nieves Gonzales
Joseph A. Fuselier
David H. Coy
Robert T. Jensen
Dr. Terry
W. Moody

October 2016

1 In vitro and in vivo anti-tumor effects of cytotoxic camptothecin-bombesin conjugates are mediated...

Ondansetron, a serotonin 5-HT3 receptor antagonist: clinical studies in cytotoxic chemotherapy

Seynaeve, C.

January 1991

Contains fulltext : mmubn000001_125681208.pdf (publisher's version ) (Open Access)...

400 Copyright © 2013 The Korean Society of Cardiology Korean Circulation Journal

August 2016

Doxorubicin is a glycosidic anthracycline anticancer drug, and it was first isolated from Streptomyc...

Sialic acid mimetics for cancer immunotherapy

Büll, C.

January 2017

Contains fulltext : 169260.pdf (publisher's version ) (Open Access)Radboud Univers...